Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study

被引:0
|
作者
Aatke van der Maas
Bart JF van den Bemt
Gertjan Wolbink
Frank HJ van den Hoogen
Piet LCM van Riel
Alfons A den Broeder
机构
[1] Sint Maartenskliniek,Department of Rheumatology
[2] Sint Maartenskliniek,Department of Pharmacy
[3] Reade,Department of Rheumatology
[4] Radboud University Nijmegen Medical Center,Department of Rheumatology
关键词
Rheumatoid arthritis; Infliximab; Therapeutic drug monitoring; Serum trough levels; Anti-infliximab antibodies; Low disease activity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    van der Maas, Aatke
    van den Bemt, Bart J. F.
    Wolbink, Gertjan
    van den Hoogen, Frank H. J.
    van Riel, Piet L. C. M.
    den Broeder, Alfons A.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [2] The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Aguado, Pilar
    Jurado, Teresa
    Martin-Mola, Emilio
    Balsa, Alejandro
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1098
  • [3] Serum trough infliximab and anti-infliximab antibodies in a cohort of gastroenterology and rheumatology patients' infliximab therapeutic drug monitoring
    Barlow, Nicola L.
    Mohammed, Pervaz
    Berg, Jonathan D.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2016, 53 (04) : 477 - 484
  • [4] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [5] Anti-infliximab antibodies in RA patients treated with infliximab.
    Wolbink, GJ
    Lems, WF
    Nurmohamed, MT
    Vis, M
    Voskuyl, AE
    Stapel, S
    de Groot, E
    Tak, PP
    Dijkmans, BA
    Aarden, L
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S187 - S187
  • [6] TROUGH INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES IN SPONDYLOARTHRITIS PATIENTS ON TREATMENT WITH LOW DOSE INFLIXIMAB: A SINGLE CENTRE CROSS-SECTIONAL STUDY
    Patil, A.
    Upadhyaya, S. K.
    Dawar, R.
    Vaishnav, B.
    Dadhaniya, N.
    Gupta, S. J.
    Handa, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1292 - 1292
  • [7] ESTABLISHING CUT-OFF OF INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES BY COMMERCIAL ELISA IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Hernandez, Diana
    Valor, Lara
    de la Torre, Inmaculada
    Martinez, Lina
    Carlos Nieto, Juan
    del Rio, Tamara
    Naredo, Esperanza
    Gonzalez, Carlos
    Lopez-Longo, Javier
    Montoro, Maria
    Monteagudo, Indalecio
    Carreno, Luis
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A11 - A11
  • [8] Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
    Finckh, Axel
    Dudler, Jean
    Wermelinger, Felix
    Ciurea, Adrian
    Kyburz, Diego
    Gabay, Cem
    Bas, Sylvette
    [J]. JOINT BONE SPINE, 2010, 77 (04) : 313 - 318
  • [9] Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 385 - 386
  • [10] Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
    Svenson, M.
    Geborek, P.
    Saxne, T.
    Bendtzen, K.
    [J]. RHEUMATOLOGY, 2007, 46 (12) : 1828 - 1834